These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23465675)

  • 21. Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy.
    Yukawa T; Shimizu K; Hirami Y; Maeda A; Yasuda K; Nakata M
    Asian Cardiovasc Thorac Ann; 2013 Dec; 21(6):732-4. PubMed ID: 24569337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.
    Hamamoto Y; Kataoka M; Yamashita M; Nogami N; Sugawara Y; Kozuki T; Sawada S; Suehisa H; Shinohara S; Nakajima N; Shinkai T
    Jpn J Radiol; 2012 Oct; 30(8):671-5. PubMed ID: 22836906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-FDG PET/CT demonstrating response to targeted therapy in synchronous metastatic adenocarcinoma of the lung and poorly differentiated carcinoma of the thyroid.
    Kumar NS; Basu S
    Natl Med J India; 2015; 28(3):155. PubMed ID: 26724353
    [No Abstract]   [Full Text] [Related]  

  • 24. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
    Chiu CH; Yeh YC; Lin KH; Wu YC; Lee YC; Chou TY; Tsai CM
    J Thorac Oncol; 2011 Oct; 6(10):1697-703. PubMed ID: 21869716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.
    Rizk N; Downey RJ; Akhurst T; Gonen M; Bains MS; Larson S; Rusch V
    Ann Thorac Surg; 2006 Mar; 81(3):1076-81. PubMed ID: 16488726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.
    Tsutani Y; Miyata Y; Yamanaka T; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):17-23. PubMed ID: 23246051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.
    Abelson JA; Murphy JD; Trakul N; Bazan JG; Maxim PG; Graves EE; Quon A; Le QT; Diehn M; Loo BW
    Lung Cancer; 2012 Dec; 78(3):219-24. PubMed ID: 23009727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fetal Adenocarcinoma of the Lung].
    Ito K; Kasai Y; Masuya D; Takata N; Tanaka Y; Kume S; Inoue S; Monden K; Okada N; Yoshimatsu H; Suzuki Y
    Kyobu Geka; 2018 Jun; 71(6):438-441. PubMed ID: 30042244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small lesion, severe consequences. An intriguing ventilation-perfusion scintigraphy.
    De Raedt N; Gheysens O; Nackaerts K; Dooms C; De Ruysscher D; Deroose CM
    Am J Respir Crit Care Med; 2014 Aug; 190(4):e12-3. PubMed ID: 25127312
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose Uptake Values in Positron Emission Tomography Are Useful to Predict Survival after Sublobar Resection for Lung Cancer.
    Nakamura H; Saji H; Marushima H; Tagaya R; Kimura H; Takagi M
    Thorac Cardiovasc Surg; 2017 Mar; 65(2):150-157. PubMed ID: 26909560
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
    Murakami S; Saito H; Sakuma Y; Kondo T; Oshita F; Ito H; Tsuboi M; Hasegawa C; Yokose T; Kameda Y; Nakayama H; Yamada K
    Eur J Radiol; 2012 Aug; 81(8):1891-5. PubMed ID: 21546177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.
    Sasada S; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Okada M
    Ann Thorac Surg; 2014 Aug; 98(2):417-22. PubMed ID: 24961842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.
    Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):70-3. PubMed ID: 19359282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
    Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
    J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invited commentary.
    Donington JS
    Ann Thorac Surg; 2012 Feb; 93(2):403-4. PubMed ID: 22269704
    [No Abstract]   [Full Text] [Related]  

  • 40. [Positron emission tomography/computed tomography for lung cancer staging].
    Ladrón de Guevara H D; Furnaro L F; Yévenes A S; Clavero R JM; Lazo P D; Rodríguez D P; Piottante B A; Pefaur D R; Pardo B C
    Rev Med Chil; 2015 Jan; 143(1):22-9. PubMed ID: 25860265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.